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Recent advances in imaging techniques and understanding of
differences in the molecular biology of adipose tissue has
rendered classical anatomy obsolete, requiring a new classifi-
cation of the topography of adipose tissue. Adipose tissue is
one of the largest body compartments, yet a classification that
defines specific adipose tissue depots based on their anatomic
location and related functions is lacking. The absence of an
accepted taxonomy poses problems for investigators studying
adipose tissue topography and its functional correlates. The
aim of this review was to critically examine the literature on
imaging of whole body and regional adipose tissue and to
create the first systematic classification of adipose tissue to-
pography. Adipose tissue terminology was examined in over
100 original publications. Our analysis revealed inconsisten-
cies in the use of specific definitions, especially for the com-
partment termed “visceral” adipose tissue. This analysis leads
us to propose an updated classification of total body and
regional adipose tissue, providing a well-defined basis for
correlating imaging studies of specific adipose tissue depots
with molecular processes.
Key words: body composition, computed tomography,
magnetic resonance imaging, body fat
Introduction
Increased adipose tissue mass is the primary phenotypic
characteristic of obesity. The amount and distribution of
adipose tissue is associated with many of the adverse con-
sequences of obesity, such as coronary artery disease and
type 2 diabetes (1–4).
Recently, it has been discovered that adipose tissue is not
a single homogeneous compartment, but rather a tissue with
specific regional depots with varying biological functions
(5–7). Moreover, individual adipose tissue compartments
have stronger associations with physiological and patholog-
ical processes than does total adipose tissue mass (6,8–11).
Although there is intense and increasing interest in re-
gional adipose tissue compartments, there is still little avail-
able information or formal consensus on the nomenclature
of regional adipose tissue depots. Whereas computerized
axial tomography (CT)1 and magnetic resonance imaging
(MRI) are often used to quantify adipose tissue volumes,
authors vary greatly in their definition of the adipose tissue
compartments they measure.
Here we review some of the complexities posed by quan-
tification of adipose tissue by imaging methods, focusing on
classification issues. The first section is an overview of
differences between adipose tissue and the group of molec-
ular-level components referred to collectively as fat. The
next section explores traditional adipose tissue classification
systems. We then critically examine imaging-related termi-
nology used in metabolic research. As part of our review, in
each section, we recommend what we believe is appropriate
adipose tissue terminology for providing a unified imaging-
based classification. We conclude with recommendations
for future research.
Adipose Tissue vs. Fat
Imaging methods, CT and MRI, quantify “adipose tissue”
volume as voxels or volume elements. While often referred
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to as “fat” according to the five-level body composition
model, adipose tissue and fat are different components (12).
The distinction between fat and adipose tissue in common
usage is usually irrelevant, and the terms are almost always
used interchangeably. However, in the body composition
and metabolism field, “fat” and “adipose tissue” are distinct
and different compartments (Figure 1) (12), and their taxo-
nomic separation is important when measuring their mass
and metabolic characteristics.
A component at the tissue-organ body composition level
(12), adipose tissue is a specialized loose connective tissue
that is extensively laden with adipocytes. Adipose tissue has
mainly been viewed as an energy storage depot, thermal
insulator, and mechanical cushion in mammals. The 70-kg
Reference Man has 15 kg of adipose tissue, representing
21% of body mass (13). The percentage is higher in women,
the elderly, and overweight subjects. Adipose tissue is an-
atomically distributed throughout the human body, and the
pattern of adipose tissue distribution is influenced by many
factors, including sex, age, genotype, diet, physical activity
level, hormones, and drugs (14–19).
In contrast to adipose tissue, the molecular level or chem-
ical component fat is usually lipid in the form of triglycer-
ides (12). Although fat is found primarily in adipose tissue,
fat also exists in other tissues, especially in pathological
conditions such as hepatic steatosis and various forms of
lipidosis. Triglycerides in other tissues, such as in skeletal
muscle, can be quantified by magnetic resonance spectroscopy
(20). The most widely used current method for quantifying fat
in vivo is DXA, whereas chemical analysis is used in vitro
(21,22). Adipose tissue contains 80% fat; the remaining
20% is water, protein, and minerals (13).
Investigators in the field of metabolism often quantify fat
or adipose tissue and find that the total mass of the two
compartments in adults is similar, but not identical (23–27).
This review concentrates on regional and total body adipose
tissue, not fat or lipid, as quantified by the two main
imaging methods, CT and MRI.
Traditional Adipose Tissue Classification
Classical anatomy was mainly organ-centered, without
recognizing the specialized organ-like functions of different
tissues. This was especially true of adipose tissue, which
only recently has been recognized as an “endocrine organ”
(28). We reviewed many 19th and early 20th century anat-
omy texts and found a conspicuous lack of detail in regard
to adipose tissue classification.
Among typical approaches we did find in early texts, one
is based on simple anatomic adipose tissue groupings not
defined by traditional anatomic landmarks. According to
this approach, adipose tissue can be typically organized into
simple categories such as subcutaneous adipose tissue, or-
gan-surrounding adipose tissue, interstitial adipose tissue,
and adipose tissue in bone marrow (29). Subcutaneous
adipose tissue is known to gross anatomists as superficial
fascia and is defined as the adipose tissue layer found
between the dermis and the aponeuroses and fasciae of the
muscles. Adipose tissue is sometimes named specifically
for the organ it surrounds, as in “perirenal adipose tissue.”
Interstitial adipose tissue, however, is interspersed or infil-
trated among the cells of different tissues so tightly that it is
not readily dissectible (30).
This simple adipose tissue classification system served
anatomists well for the past centuries, particularly because
the main early focus was on organs, and little clinical
pathology was directly attributable to or found within the
adipose tissue compartment.
Adipose tissue is also named according to special biolog-
ical functions, such as white, mammary gland, brown, and
bone marrow adipose tissues (31). White adipose tissue
functions mainly as an energy reservoir, insulator, and as a
source of recently discovered hormones (32). Thermogen-
esis is the main function of brown adipose tissue found in
many small mammals. Mammary gland adipose tissue plays
an important role in epithelial cell growth and milk produc-
tion, whereas bone marrow adipose tissue might participate
in hematopoiesis and osteogenesis (31).
This classification provided a clear and useful approach
for organizing some of the recognized biological functions
of adipose tissue. However, important metabolic properties
of adipose tissue depots, such as visceral adipose tissue,
cannot easily be accommodated. Also, the groupings in this
approach represent a hybrid that includes anatomic regions
(e.g., mammary glands) and functional properties (e.g., heat
production by brown adipose tissue and energy storage by
white adipose tissue), with the potential for overlap.
Adipose Tissue Classification in Radiology
The prevailing confusion and, to some extent, outdated
terminology concerning adipose tissue in the medical liter-
Figure 1: The relationship between chemical fat (or lipid) and
adipose tissue.
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ature prompted us to review papers on imaging of adipose
tissue compartments related to metabolic activity and dis-
ease. Using Medline, we examined over 100 articles with
the terms “total,” “regional,” and “visceral” adipose tissue
or fat published between 1979 and 2002. Two categories
were identified, those that evaluated whole body and those
that evaluated regional adipose tissue.
Whole-Body Imaging Studies
While investigators usually provided clear definitions of
adipose tissue depots, some reports lacked adequate detail to
evaluate component characteristics. Most articles did not
indicate whether or how adipose tissue depots other than
subcutaneous and visceral adipose tissue were measured,
even though they collectively contribute to total-body adi-
pose tissue (33,34).
Overall, the reports were concordant on a number of
measurement procedures when applied to whole-body mul-
tislice CT and MRI. First, even though its boundary is
clearly visible and thus easily quantified, bone marrow
adipose tissue was usually not included in imaging studies
of total-body adipose tissue (35). This is likely because most
investigators have little interest in bone marrow adipose
tissue estimates.
Second, adipose tissue in the head, feet, and hands is
difficult to distinguish from adipose tissue in bone marrow
with commonly applied MRI sequences, and these tissues
are usually labeled as nonadipose tissue (36,37). Neverthe-
less, a trained analyst can isolate subcutaneous adipose
tissue from bone marrow with high resolution MRI.
Third, scattered adipocytes are found within many organs
and tissues, especially skeletal muscle. Unless these adipo-
cytes clump together and form a larger mass, they may be
below the commonly applied resolution of CT and MRI,
relegating them to measurement within the nonadipose tis-
sue component. While these small adipose tissue clumps are
now below the current imaging threshold, it should be
possible in the future with MRI to establish a separate
estimate of the lipid content of scattered adipocytes by
subtracting intramyocellular lipid content measured by 1H
magnetic resonance spectroscopy from total tissue lipid
content measured by chemical shift imaging (20,38,39).
These advanced methods are revolutionizing the study of in
vivo biology and redefining the study of human anatomy.
Thus, “total-body” adipose tissue measured by imaging
methods in the current published literature is usually differ-
ent from the actual volume of adipose tissue determined by
dissection and histological analysis. Nevertheless, the po-
tential exists with developing techniques to accurately quan-
tify total body adipose tissue in vivo.
Some whole-body imaging studies grouped adipose tis-
sue compartments according to metabolic activity. Barnard
et al. subdivided total body adipose tissue into “subcutane-
ous” and “internal” (i.e., visceral, paravertebral, and inter-
muscular) with further partitioning of visceral adipose tissue
into retro- and intraperitoneal components (33,35). This
partition of total-body adipose tissue assumes that subcuta-
neous adipose tissue and internal adipose tissue differ in
their metabolic activities. Thomas et al. (34), in their imag-
ing studies, separated internal adipose tissue into two com-
partments, visceral adipose tissue and nonvisceral adipose
tissue.
Although adipose tissue in the female breast functions
differently from other subcutaneous regions in several re-
spects (31), most investigators consider mammary adipose
tissue a portion of the subcutaneous compartment. Local-
ized fat pads, such as the synovia, were formerly classified
as mechanical adipose tissue but are now considered by
most investigators to be components of subcutaneous adi-
pose tissue.
A number of reviews explore the well-developed techni-
cal aspects of imaging methods and their validity in quan-
tifying total-body and subcutaneous adipose tissue (30,40–
42). The coefficients of variation (CV) for repeated
subcutaneous adipose tissue measurements by CT and MRI
are similar and in the range of 2% (43–45).
The subcutaneous adipose tissue of the lower trunk and
the gluteal-thigh region has a thin fascial plane dividing it
into superficial and deep portions, as shown in Figure 2
(46–49). In recent studies, both morphological and meta-
bolic differences were found between these two adipose
tissue layers (10,50,51). The majority of deep subcutaneous
adipose tissue is located in the posterior half of the abdomen,
whereas superficial subcutaneous adipose tissue is evenly dis-
tributed around the abdominal circumference (10).
These collected reports led us to propose a practical
total-body and regional adipose tissue classification system
based on the well-defined fascial planes listed in Table 1.
Total-body adipose tissue can be first divided into two main
measurable components, subcutaneous and internal. Subcu-
taneous adipose tissue is well defined and has clear ana-
tomic demarcations, as noted in the table. Internal adipose
tissue is divided into visceral and nonvisceral components.
Among the nonvisceral components, some perimuscular
adipose tissue regions are specially named. For example,
when distributed among muscles, they are named as inter-
muscular adipose tissue, and when adjacent to bones, they
are named as paraosseal adipose tissue. The fascial planes
separating perimuscular adipose tissue from adjacent adi-
pose tissue compartments are sometimes, but not always,
visible when images are prepared using typical MRI acqui-
sition sequences (Figure 3A). These fascial planes are vis-
ible in most subjects when high-resolution images are prepared
(Figure 3B). Additionally, the perimuscular and intramus-
cular adipose tissue depots are small and are thus not
accurately measurable by traditional cadaver dissection. Re-
cently, advanced digital photography (30) and microdissec-
Adipose Tissue Classification, Shen et al.
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tion (52) methods have provided a means of accurately
estimating the areas or volumes of these difficult-to-dissect
adipose tissue compartments and can be applied in human
cadaver or animal studies to serve as the imaging-method
criterion.
Absolute and relative visceral adipose tissues have been
associated with the greatest health risk (53,54). Authors
vary widely in their definitions and descriptions of visceral
adipose tissue. Some reports did not provide any anatomic
demarcations of visceral adipose tissue compartments
(11,55–67). Contrary to the simple view of visceral adipose
tissue held by many authors, there are important differences
in the metabolic and functional properties of depots within
the “visceral adipose tissue” compartment. Accordingly, in
the following section, we present a critical review of pre-
vious visceral adipose tissue studies, along with a detailed
classification of visceral adipose tissue.
Visceral Adipose Tissue
The word “viscera” originates from Latin (68) and is
defined as “organs in the cavities of the body” (68–70).
Because there are three main body cavities, it is reasonable
to assume that visceral adipose tissue (VAT) consists of
adipose tissue (AT) distributed in the three body cavities:
intrathoracic (ITAT), intraabdominal (IAAT), and intrapel-
vic (IPAT). The physical location of these three cavities is
from cephalad to caudad, and axial image acquisition pro-
vides the landmarks for roughly separating ITAT from
IAAT and IAAT from IPAT. Accordingly, investigators
have studied the metabolic characteristic of visceral adipose
tissue found in these three different compartments. Most
investigators report visceral adipose tissue as IAAT or the
sum of IAAT and IPAT.
The CVs of visceral adipose tissue estimates by imaging
methods are well studied and extensively reviewed. The
CVs for VAT measurements by MRI are 9% to 18%
(44,45,71,72) and by CT are 2% (43). The lower CV of
CT is usually ascribed to a shorter image acquisition time,
and CT is thus less vulnerable to image artifacts produced
by peristaltic gastrointestinal tract movement (73). The sig-
nal intensity of MRI pixels from the same tissue may vary
from region to region due to magnetic field heterogeneity.
There may also be some sequence-related artifacts with
MRI, such as chemical shift and blood flow artifacts. These
effects collectively lower the accuracy and precision of MRI
visceral adipose tissue estimates, particularly as image anal-
ysis requires establishing the irregular boundaries between
VAT and other tissues and organs.
As a stimulus for review and as a means of evoking the
prevailing confusion in the literature, we now examine
earlier studies in the context of VAT as the sum of three
distinct components.
VAT  ITAT  IAAT  IPAT. Although viscera are
distributed throughout all body cavities, very few investi-
gators defined VAT in humans as the sum of ITAT, IAAT,
and IPAT (74–76). This definition of VAT is applied in the
animal literature (77). It is not known whether the three
VAT components have distinct metabolic characteristics.
The least studied of these three components is ITAT. The
ITAT is mainly distributed surrounding the heart, and the
physiological role of ITAT is in an early stage of investi-
gation. In animal studies, Marchington et al. (78) found that
epicardial adipose tissue has a greater capacity for fatty acid
release than adipose tissue elsewhere in the body. Cardiac
adipose tissue may supply energy for the adjacent myocardium
and serve as a buffer against toxic levels of free fatty acids.
IPAT is usually quantified together with IAAT. However,
when studied separately from IAAT, the metabolic proper-
ties of IPAT and IAAT differ (49,79). Part of the reason for
this metabolic difference is that IAAT represents both extra-
and intraperitoneal adipose tissue, whereas IPAT represents
mainly extraperitoneal adipose tissue (49).
Figure 2: Abdominal axial CT scans of an obese (A) and a thin
subject (B). Subcutaneous adipose tissue is divided into superficial
and deep subcutaneous adipose tissue by a fascial plane, as indi-
cated by the white arrows.
Adipose Tissue Classification, Shen et al.
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VAT  IAAT  IPAT. The VAT compartment as defined
in some reports included IAAT and IPAT (33,34,37,79) that
ranged anatomically from the femoral heads to the liver
dome or base of the lungs. Whole-body CT and MRI scans
usually consisted of multiple slices at predefined intervals
(e.g., 5 cm). With the 5-cm intervals often used in MRI
protocols, VAT was frequently defined as located within the
seven slices extending from two below and four above the
L4–L5 level (37). The IAAT and IPAT components are
anatomically connected, and it is thus reasonable to study
them together.
VAT  IAAT. Most of the reviewed earlier studies de-
fined VAT as IAAT only, with a range from 5 cm below
L4–L5 to the slice corresponding to the superior border of
the liver (8,9,40,80–87). Some investigators additionally
divided VAT into intraperitoneal and retroperitoneal adi-
pose tissue (9,82,83,86,87). Because the parietal peritoneum
rarely is visible on cross-sectional images (73), some inves-
tigators adopted an arbitrary method in which the marker
was used to draw a straight line across the anterior border of
L4–L5 and the psoas muscles, continuing on a tangent
toward the posterior borders of the ascending and descend-
ing colon, and extending to the abdominal wall. However,
the lack of exact boundaries between the intraperitoneal and
retroperitoneal space renders this subdivision only an ap-
proximation. Some investigators referred to “abdominal
VAT” instead of “VAT” to indicate that they were actually
measuring IAAT (34,36,88,89).
VAT  Intraperitoneal Adipose Tissue. A few studies
defined VAT solely as intraperitoneal adipose tissue, which
is drained by the portal vein, whereas blood from retroper-
itoneal adipose tissue empties into the inferior vena cava
(90,91). Although limiting the definition of VAT to intra-
peritoneal adipose tissue is inconsistent with the term “vis-
cera,” the relationships between intraperitoneal adipose tis-
sue and metabolic disorders have aroused considerable
research interest. Abate et al. (91) proposed that metabolic
differences exist between intraperitoneal and retroperitoneal
adipose tissue. Although the fatty acid component of omen-
tal and mesenteric sites is not different from subcutaneous
and retroperitoneal sites (36), it is currently hypothesized
that the direct exposure of liver cells through the portal
circulation to high concentrations of free fatty acids and/or
other metabolites derived from intraperitoneal adipose tis-
sue is responsible for the increased frequency of dyslipide-
mia, hyperinsulinemia, and other metabolic complications
associated with abdominal obesity (43,92).
Ideally the study of VAT should include all adipose tissue
in the thoracic, abdominal, and pelvic cavities. However,
many investigators are interested only in some subdivisions
of VAT. Accordingly, it is reasonable to suggest that any
VAT depot under study should be accurately named and
characterized to avoid further confusion. Metabolic charac-
teristics can be attributed to IAAT as a whole
(9,82,83,86,87,90,91), although this may simply reflect the
relatively large amount of highly active intraperitoneal ad-
Table 1. Proposed classification of total body adipose tissue
Adipose tissue compartment Definition
Total adipose tissue Sum of adipose tissue, usually excluding bone marrow and adipose tissue
in the head, hands, and feet.
Subcutaneous adipose tissue The layer found between the dermis and the aponeuroses and fasciae of
the muscles. Includes mammary adipose tissue.
Superficial subcutaneous adipose tissue The layer found between the skin and a fascial plane in the lower trunk
and gluteal-thigh area.
Deep subcutaneous adipose tissue The layer found between the muscle fascia and a fascial plane in the
lower trunk and gluteal-thigh areas.
Internal adipose tissue Total adipose tissue minus subcutaneous adipose tissue.
Visceral adipose tissue (See Table 2) Adipose tissue within the chest, abdomen, and pelvis.
Nonvisceral internal adipose tissue Internal adipose tissue minus visceral adipose tissue.
Intramuscular adipose tissue Adipose tissue within a muscle (between fascicles).
Perimuscular adipose tissue Adipose tissue inside the muscle fascia (deep fascia), excluding
intramuscular adipose tissue.
Intermuscular adipose tissue Adipose tissue between muscles.
Paraosseal adipose tissue Adipose tissue in the interface between muscle and bone (e.g.,
paravertebral).
Other nonvisceral adipose tissue Orbital adipose tissue; aberrant adipose tissue associated with
pathological conditions (e.g., lipoma).
Adipose Tissue Classification, Shen et al.
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ipose tissue (e.g., mesenteric and omental) found in this
compartment. With increasing evidence of metabolic differ-
ences between intraperitoneal and extraperitoneal adipose
tissues, it is reasonable to consider the intraperitoneal adipose
tissue of both the abdominal and pelvic regions together,
particularly because these compartments are contiguous.
We summarize the main VAT components in Table 2 and
propose this as a classification and nomenclature for future
studies. Because there is no adipose tissue adjacent to the
pleura, we use pericardium instead of pleura to further
separate the adipose tissue components of the thoracic cav-
ity (Figure 4). In the studies we reviewed, rather than
measuring total extraperitoneal adipose tissue, most inves-
tigators only quantified retroperitoneal adipose tissue be-
cause it could be easily separated from intraperitoneal adi-
pose tissue by an arbitrary line.
Figure 3: (A) Arrows indicate the fascial planes separating perimuscular from subcutaneous adipose tissue as observed on an axial leg
typical resolution MRI scan. (B) Arrows indicate the fascial planes separating perimuscular from subcutaneous adipose tissue as observed
on an axial lower leg high resolution MRI scan. The intramuscular adipose tissue is clearer in image B than in image A.
Adipose Tissue Classification, Shen et al.
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The traditional CT and MRI protocols now in use are not
capable of separating all of the compartments listed in Table
2. On the other hand, retroperitoneal components such as
pararenal adipose tissue are clearly visible on some conven-
tionally acquired MRI scans (Figure 5). With a smaller field
of view, higher resolution, and thinner slices, it may be
possible to separate all of the adipose tissue depots from one
another with the expectation of major technical advances in
the future.
The distribution of VAT is shown in photographs of the
National Library of Medicine’s Visible Woman and Visible
Man (Figures 6-8) (93,94). Because VAT seems to be
metabolically heterogeneous, a reasonable future goal is to
separately examine specific compartments as outlined in
Table 2.
Single-Slice Studies
In addition to volume quantification of VAT by multiple-
slice and whole-body imaging protocols, VAT is often
reported as the area of a single slice. Because of the cost of
whole-body scans and concerns over exposure to radiation,
single-slice studies have often been used, although they are
less accurate (95). The single-slice CT and MRI studies are
usually performed at the L4–L5 level, which, in addition to
omental, mesenteric, and retroperitoneal compartments, in-
cludes many other smaller adipose tissue compartments.
VAT and IAAT are terms that were often used interchange-
ably in earlier reports. It is important to recognize that
single-slice studies only provide an area when reporting
“VAT,” in contrast to the volumes reported in multiple-slice
studies.
There is also some inconsistency in the anatomical bound-
aries used in single-slice studies. Clasey et al. (96), for exam-
ple, used the innermost aspect of the abdominal and oblique
muscle walls, rather than the midpoint or the outermost aspect
of the muscle walls, for measuring “VAT.” The internal
boundary of the muscle walls was used in most of the studies
we reviewed and did not include intermuscular and paraverte-
bral adipose tissues (44,51,61,62,66,79,81,82,97–110), which
we propose should be included as nonvisceral adipose tissue.
Figure 4: Arrows indicate the pericardium separating intrapericar-
dial and extrapericardial adipose tissues on a gated cardiac image.
Figure 5: Arrows indicate the fascial planes separating pararenal
from adjacent adipose tissue compartments on a typical resolution
axial abdominal MRI scan.












Retroperitoneal (e.g., perirenal, pararenal,
periaortic, and peripancreatic)
Intrapelvic (e.g., parametrial, retropubic,
paravesical, retrouterine, pararectal,
retrorectal)
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These adipose tissue compartments increase in size with age
(33) and can be large in obese subjects.
Summary
Investigators differ in their interests in and definitions of
various adipose tissue compartments. A consistent and log-
ical classification adapted to imaging methods will allow
investigators to compare physiological and metabolic stud-
ies of adipose tissue and resolve some of the confusion in the
current literature. Specifically, we propose the following:
● Refer to components evaluated by CT and MRI as “adi-
pose tissue” instead of the chemical term “fat.” Because
“body fat” is also measured (e.g., by DXA), this will
leave no question as to what body constituent is actually
being evaluated.
Figure 6: VAT distribution in the Visible Woman. Contiguous areas from 1-mm-thick slices are plotted across the thoracic, abdominal, and
pelvic region. Reprinted with permission from the National Library of Medicine.
Figure 7: The two VAT compartments in a coronal section of the
Visible Man. Reprinted with permission from the National Library
of Medicine.
Figure 8: Main adipose tissue compartments in an axial section of
the Visible Man. Reprinted with permission from the National
Library of Medicine.
Adipose Tissue Classification, Shen et al.
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● Separate “total-body adipose tissue” into two categories:
subcutaneous and internal. These are well demarcated
and leave little room for confusion.
● Separate internal adipose tissue into two discrete compo-
nents: “visceral” and “nonvisceral.” VAT should appro-
priately include two cavities: the thoracic and abdomi-
nopelvic cavity. The abdominopelvic cavity can be
further divided into intraperitoneal and extraperitoneal
regions.
● While there is some inconsistency in the anatomical
boundaries in single-slice studies of the abdomen, we
suggest that the inner boundary of the abdominal muscle
wall should be used as the limit for VAT. This boundary
does not include intermuscular and paravertebral adipose
tissue, which should be included as nonvisceral adipose
tissue.
● While, at present, the main imaging focus is on the total
volume of adipose tissue structures, a growing interest
centers on tissue quality. Chemical shift imaging can
provide information on adipose tissue lipid content
(38,39), and proton spectroscopy provides estimates of
tissue-free fatty acid composition (111). These advanced
magnetic resonance methods have great promise in the
field of obesity research. Combining these tissue quality
assessment methods with high-resolution image acquisi-
tion holds great future promise in adipose tissue quanti-
fication.
It was the purpose of this paper to clearly define the
adipose tissue components in published reports using a
precise classification. This will, over the long term, allow
elucidation of the genetic and metabolic properties of spe-
cific adipose tissue depots, their interaction, and their over-
all orchestrated role in energy homeostasis.
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